Banyan Biomarkers, Inc
9
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
22.2%
2 terminated/withdrawn out of 9 trials
77.8%
-8.7% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Evaluation of Mild TBI in Collegiate Athletes
Role: lead
Evaluation of Biomarker Kinetics After Mild Brain Injury Trauma
Role: lead
Evaluation of Biomarkers of Traumatic Brain Injury
Role: lead
Fresh Intravenous Blood Samples for TBI Diagnostic Assay Development With Philips Point of Care System
Role: lead
Biomarkers of Mild and Moderate Traumatic Brain Injury
Role: lead
EVALUATION OF BIOMARKERS OF TRAUMATIC BRAIN INJURY EXTENSION STUDY
Role: lead
Brain Injury Biomarkers in the General Population
Role: lead
A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes
Role: lead
Biomarkers of Brain Injury: Magnitude and Outcome of Mild and Moderate TBI
Role: lead
All 9 trials loaded